CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 28 filers reported holding CATABASIS PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,000 | -100.0% | 233 | -100.0% | 0.00% | -100.0% |
Q3 2020 | $18,866,000 | -3.7% | 3,047,800 | 0.0% | 0.04% | -8.3% |
Q2 2020 | $19,597,000 | +54.9% | 3,047,800 | 0.0% | 0.05% | +29.7% |
Q1 2020 | $12,648,000 | +0.8% | 3,047,800 | +43.6% | 0.04% | +32.1% |
Q4 2019 | $12,546,000 | +6.1% | 2,122,800 | -3.0% | 0.03% | -3.4% |
Q3 2019 | $11,823,000 | -33.1% | 2,189,400 | 0.0% | 0.03% | -32.6% |
Q2 2019 | $17,668,000 | +1.9% | 2,189,400 | 0.0% | 0.04% | 0.0% |
Q1 2019 | $17,340,000 | +280.3% | 2,189,400 | +109.8% | 0.04% | +258.3% |
Q4 2018 | $4,560,000 | – | 1,043,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eversept Partners, LP | 522,042 | $1,117,170 | 0.13% |
XTX MARKETS LLC | 26,041 | $56,000 | 0.12% |
Samsara BioCapital, LLC | 300,000 | $642,000 | 0.06% |
Ikarian Capital, LLC | 650,000 | $1,392,000 | 0.06% |
Opaleye Management Inc. | 187,750 | $402,000 | 0.05% |
SABBY MANAGEMENT, LLC | 108,026 | $231,000 | 0.04% |
Anson Funds Management LP | 97,601 | $209,000 | 0.04% |
Virtu Financial LLC | 83,221 | $178,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 47,084 | $101,000 | 0.02% |
WEXFORD CAPITAL LP | 19,512 | $42,000 | 0.01% |